Abstract: The present invention relates to polymorphic forms of the compound of Formula I (i.e., ethyl 2-cyano-3,12-dioxokana-1,9(11)-dien-28-oate (CDDO ethyl ester)) and methods of using them for treating a variety of disease states such as cancer and conditions associated with inflammation.
Type:
Application
Filed:
May 22, 2017
Publication date:
December 14, 2017
Applicants:
Applied Pharmaceutical Science Inc.
Inventors:
Xiaohong Zhang, Lu Song, Wendong Sun, Kaiyang Liu, Chunlei Han
Abstract: The present invention relates to polymorphic forms of the compound of Formula I (i.e., ethyl 2-cyano-3,12-dioxoIeana-1,9(11)-dien-28-oate (CDDO ethyl ester)) and methods of using them for treating a variety of disease states such as cancer and condisitons associated with inflammation.
Type:
Grant
Filed:
December 6, 2012
Date of Patent:
May 23, 2017
Assignee:
Applied Pharmaceutical Science, Inc.
Inventors:
Xiaohong Zhang, Lu Song, Wendong Sun, Kaiyang Liu, Chunlei Han